Blog

In a court decision that could open the floodgates for drug promotion, an appellate court has thrown out the conviction of a drug salesman who promoted a drug for off-label use citing his free speech rights. Alfred Caronia worked for Orphan Medical where he sold the narcolepsy drug Xyren. He […]

Once again we are reminded how money talks and drug companies will do whatever it takes to sell their product, even if it is illegal, not to mention unethical. The state of Maine is the latest state expected to receive in excess of $1.2 million from GlaxoSmithKline LLC (GSK) over […]

By the end of the year, the U.S. Food and Drug Administration (FDA) had stated it would make sure that high-risk medical devices were approved through the most stringent premarket approval (PMA) review process to assure the safety of consumers. But it looks as though that will not happen. High-risk […]

Boehringer Ingelheim, a German drug company and maker of the blood thinner Pradaxa, must pay the federal government $95 million in compensation for defrauding Medicare. The government charged that Boehringer Ingelheim promoted their drug “off label” meaning for uses they had not received regulatory approval by the U.S. Food and […]

With about 7,700 pharmacies in Florida, it remains a mystery as to how they compound drugs, even to state officials who should be monitoring them. Last week, Florida regulators issued an emergency order requiring those pharmacies to complete a survey about exactly how they compound drugs and how much material […]

The manufacturers of defective medical devices have been the focus of a number of lawsuits filed by the Mass Tort Unit of Searcy Denney this week. A new lawsuit was filed in the United States District Court for the Middle District of Florida, Tampa Division, against Mentor Worldwide (a Delaware […]